Skip to main content
Erschienen in: BMC Neurology 1/2022

Open Access 01.12.2022 | Case report

A case of Lymphoplasmacyte-rich meningioma mimicking pachymeningitis

verfasst von: Yue Zhang, Xiang Zhang, Abhijeet Kumar Bhekharee, Zunguo Du, Shuguang Chu

Erschienen in: BMC Neurology | Ausgabe 1/2022

Abstract

Background

Lymphoplasmacyte-rich meningioma (LPRM) is a rare form of meningioma characterized by prominent lymphoplasmacytic infiltrates into the tumor. Report of flat growth of LPRM mimicking pachymeningitis is rare in the literature.

Case presentation

A 55-year-old female who suffered from episodes of headache and seizures has been diagnosed with pachymeningitis for 4 years because post contrast brain MRI demonstrated enhanced carpet-like dura lesion in the left frontal lobe. The lesion kept unchanged on yearly follow-ups until a recent brain MRI found the lesion grew significantly into a mass. The lesion was resected and pathology suggested LPRM.

Conclusion

LPRM may present as carpet-like growth pattern on MRI. Long-term follow-up in patients with pachymeningitis is necessary.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
MRI
Magnetic resonance imaging
CSF
Cerebrospinal fluid
LPRM
Lymphoplasmacyte-rich meningioma
EPM
en plaque Meningiomas
EMA
Epithelial membrane antigen
VIM
Vimentin
PR
Progesterone receptor
IHP
Idiopathic hypertrophic pachymeningitis

Background

Lymphoplasmacyte-rich meningioma (LPRM) is an extremely rare histological variant of meningioma characterized by prominent lymphoplasmacytic infiltrates into the tumor. It accounts for 0.51% of intracranial meningiomas [1]. Meningiomas usually manifest as single or multiple pachymeningeal masses on MRI while some rare variants, especially en plaquemeningiomas (EPM) may present with carpet-like growth pattern. Occasionally such growth pattern can also be observed in LPRMs [18]. Herein, we describe a case of LPRM mimicking pachymeningitis on brain MRI initially. Four years after onset, the lesion grew into an obvious mass in the left frontal lobe. The diagnosis of LPRM was confirmed by dural biopsy.

Case presentation

A 55-year-old female was admitted for a 4-year history of recurrent psychiatric problems, headache, and seizures. In June 2016, the patient developed irritation, auditory hallucination and delusion. Brain CT revealed hyperdensity in the left frontal dura matter (Fig. 1 A). Symptoms were soon controlled by risperidone. On 11 November 2016, she suffered from acute severe headache, drowsiness, dullness and seizures. Intravenous diazepam and valproate were administered to control seizures. Post-contrast MRI of brain revealed lineal dural enhancement in the left forehead and pachymeningitis was considered (Fig. 1 B-D). Differentials included meningioma, lymphoma, neurosarcoidosis, Rosai Dorfman disease and Erdheim Chester disease. However, the patient refused to receive dural matter biopsy. In the past 4 years, she had suffered from episodic psychiatric problems, headache and seizures. Intravenous mannitol and diazepam could alleviate symptoms and no long-term medications were given. Brain MRIs were performed every year and they showed the lesion unchanged until December 2019 when brain CT and MRI revealed that the lesion had grown into a mass (Fig. 1 E–G). Past history was unremarkable except chronic hepatitis B and 10-year-long well controlled hypertension.
She was admitted in April 2020. On admission, she was alert, oriented but slightly apathetic. Cognitive function was not impaired. Chaddock sign was present in the right. Laboratory tests were unremarkable except elevated serum IgG to 18.1 g/l (reference range: 7.51–15.6). Lumbar puncture revealed an opening pressure of 200mmH2O. Analysis of cerebrospinal fluid (CSF) showed normal cell count, glucose, protein and chloride levels. CSF IgG4 was undetectable. Malignant cell was not found in CSF. The patient received left frontal dural mass biopsy, and it showed clustered nests of meningothelial cells in an abundant inflammatory and collagenated background (Fig. 2 A-C). These meningothelial cells were positive for VIM, EMA, PR, and SSTR2 (Fig. 2 D, E). The inflammatory cells were mixed and polyclonal, where lymphoma and histiocytosis were excluded. They were partially positive for CD20, CD3, CD79a, CD68, and CD138 (Fig. 2 F, G). Fewer IgG4 + plasma cells were found (Fig. 2 H). Staining of CD1a, kappa/lambda chains, and S100 was negative (Fig. 2 ). B cell gene rearrangement showed negative results. LPRM was thus considered. After surgery, the patient became lethargic. Intravenous methylprednisolone of 500 mg was administered daily for 3 days and then tapered off. Her mental status improved rapidly and dural enhancement on MRI fainted 2 weeks after corticotherapy (Fig. 1 H). Six months after surgery, the patient was asymptomatic and the MRI manifestation was similar to that of half a year ago.

Discussion and conclusion

LPRM is an extremely rare histological variant of WHO grade I meningioma, characterized by infiltration of lymphocytes and plasma cells in the tumor. On MRI, most LPRMs present as dural masses, but flat growth has been occasionally described in the literature [18]. Several case reports mentioned they might mimic idiopathic hypertrophic pachymeningitis (IHP) [46] which is a disease characterized by inflammation and fibrosis of the dura mater without determined pathogenesis. In the present case, the initial brain MRI revealed lineal enhancement without obvious mass, so the diagnosis of IPH was preferred. Glucosteroids is the mainstay treatment for IPH. Long-term stability without corticotherapy is rare in this disease [9]. In this case, however, the episodic symptoms could resolve spontaneously which made the diagnosis of IPH doubtable. Other differential diagnosis included various neoplastic or non-neoplastic conditions. EPM is a special growth pattern of meningioma when tumor infiltrates the dura matter in a carpet-like appearance, rendering a thin layer in the dura. Whereas they are more inclined to involve sphenoid wing rather than convexity [10]. Dramatic osseous destruction is also an important feature. Primary pachymeningeal lymphoma accounts for 6.3% of primary CNS lymphomas [11]. Leptomeningeal involvement and parenchymal infiltration are common in pachymeningeal lymphoma. Non-neoplastic diseases, such as IgG4-related pachymeningitis, neurosarcoidosis, Rosai Dorfman disease, or Erdheim Chester disease was not supported by ancillary testing or pathology.
The nature of LPRM has not been fully understood. Some authors regard it as a mechanism of host immune resistance to the tumor [12]. So, LPRM may bear some features of inflammation, such as anemia, polyclonal gammopathy and peritumoral brain edema [2]. In our case, serum IgG was slightly elevated, however it is insufficient to reach the diagnosis. LPRM should be treated surgically, but in this case, the lesion was so diffuse that total resection of tumor was not possible. As for conservative treatment, corticotherapy and azathioprine were prescribed in one case and the tumor size slightly reduced on a 6-month-long follow-up [4]. However, Yang X et al. reported a similar case with poor porgnosis despite the use of corticotherapy [6]. In our case, corticosteroids alleviated symptoms and dural enhancement on post contrast MRI, implying the inflammatory feature of LPRM.
In conclusion, we report a case of LPRM with carpet-like growth pattern, mimicking pachymeningitis. Neuologists should be aware that LPRM can mimic pachymengintis in the early stage. Long-term follow-up is needed for pateints with pachymengiitis and dura matter biopsy are justifiable when the diagnosis of pachymenititis became doubtful.

Acknowledgements

Not applicable

Declarations

The study is approved by ethics committee of Huashan hospital.
Written informed consent was obtained from the patient and her family for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Tao X, Wang K, Dong J, et al. Clinical, Radiologic, and Pathologic Features of 56 Cases of Intracranial Lymphoplasmacyte-Rich Meningioma. World Neurosurg. 2017;106:152–64.CrossRef Tao X, Wang K, Dong J, et al. Clinical, Radiologic, and Pathologic Features of 56 Cases of Intracranial Lymphoplasmacyte-Rich Meningioma. World Neurosurg. 2017;106:152–64.CrossRef
2.
Zurück zum Zitat Zhu HD, Xie Q, Gong Y, et al. Lymphoplasmacyte-rich meningioma: our experience with 19 cases and a systematic literature review. Int J Clin Exp Med. 2013;6(7):504–15.PubMedPubMedCentral Zhu HD, Xie Q, Gong Y, et al. Lymphoplasmacyte-rich meningioma: our experience with 19 cases and a systematic literature review. Int J Clin Exp Med. 2013;6(7):504–15.PubMedPubMedCentral
3.
Zurück zum Zitat Liu JL, Zhou JL, Ma YH, Dong C. An analysis of the magnetic resonance imaging and pathology of intracal lymphoplasmacyte-rich meningioma. Eur J Radiol. 2012;81(5):968–73.CrossRef Liu JL, Zhou JL, Ma YH, Dong C. An analysis of the magnetic resonance imaging and pathology of intracal lymphoplasmacyte-rich meningioma. Eur J Radiol. 2012;81(5):968–73.CrossRef
4.
Zurück zum Zitat Hirunwiwatkul P, Trobe JD, Blaivas M. Lymphoplasmacyte-rich meningioma mimicking idiopathic hypertrophic pachymeningitis. J Neuroophthalmol. 2007;27(2):91–4.CrossRef Hirunwiwatkul P, Trobe JD, Blaivas M. Lymphoplasmacyte-rich meningioma mimicking idiopathic hypertrophic pachymeningitis. J Neuroophthalmol. 2007;27(2):91–4.CrossRef
5.
Zurück zum Zitat Cha YJ, Lee SK, Chang JH, Kim SH. Report of a rare case of atypical lymphoplasmacyte-rich meningioma in the tentorium mimicking idiopathic hypertrophic pachymeningitis. Brain Tumor Pathol. 2016;33(3):216–21.CrossRef Cha YJ, Lee SK, Chang JH, Kim SH. Report of a rare case of atypical lymphoplasmacyte-rich meningioma in the tentorium mimicking idiopathic hypertrophic pachymeningitis. Brain Tumor Pathol. 2016;33(3):216–21.CrossRef
6.
Zurück zum Zitat Yang X, Le J, Hu X, Zhang Y, Liu J. Lymphoplasmacyte-rich meningioma involving the whole intracranial dura mater. Neurol. 2018;90(20):934–5.CrossRef Yang X, Le J, Hu X, Zhang Y, Liu J. Lymphoplasmacyte-rich meningioma involving the whole intracranial dura mater. Neurol. 2018;90(20):934–5.CrossRef
7.
Zurück zum Zitat Yongjun L, Xin L, Qiu S, Jun-Lin Z. Imaging findings and clinical features of intracal lymphoplasmacyte-rich meningioma. J Craniofac Surg. 2015;26(2):e132-137.CrossRef Yongjun L, Xin L, Qiu S, Jun-Lin Z. Imaging findings and clinical features of intracal lymphoplasmacyte-rich meningioma. J Craniofac Surg. 2015;26(2):e132-137.CrossRef
8.
Zurück zum Zitat Yamaki T, Ikeda T, Sakamoto Y, Ohtaki M, Hashi K. Lymphoplasmacyte-rich meningioma with clinical resemblance to inflammatory pseudotumor. Report of two cases. J Neurosurg. 1997;86(5):898–904.CrossRef Yamaki T, Ikeda T, Sakamoto Y, Ohtaki M, Hashi K. Lymphoplasmacyte-rich meningioma with clinical resemblance to inflammatory pseudotumor. Report of two cases. J Neurosurg. 1997;86(5):898–904.CrossRef
9.
Zurück zum Zitat Karakasis C, Deretzi G, Rudolf J, Tsiptsios I. Long-term lack of progression after initial treatment of idiopathic hypertrophic pachymeningitis. J Clin Neurosci. 2012;19(2):321–3.CrossRef Karakasis C, Deretzi G, Rudolf J, Tsiptsios I. Long-term lack of progression after initial treatment of idiopathic hypertrophic pachymeningitis. J Clin Neurosci. 2012;19(2):321–3.CrossRef
10.
Zurück zum Zitat Yao A, Sarkiss CA, Lee J, Zarzour HK, Shrivastava RK. Surgical limitations in convexity meningiomas en-plaque: Is radical resection necessary? J Clin Neurosci. 2016;27:28–33.CrossRef Yao A, Sarkiss CA, Lee J, Zarzour HK, Shrivastava RK. Surgical limitations in convexity meningiomas en-plaque: Is radical resection necessary? J Clin Neurosci. 2016;27:28–33.CrossRef
11.
Zurück zum Zitat Karschnia P, Batchelor TT, Jordan JT, et al. Primary dural lymphomas: Clinical presentation, management, and outcome. Cancer. 2020;126(12):2811–20.CrossRef Karschnia P, Batchelor TT, Jordan JT, et al. Primary dural lymphomas: Clinical presentation, management, and outcome. Cancer. 2020;126(12):2811–20.CrossRef
12.
Zurück zum Zitat Kurmi DJ, Sharma A, Mittal RS, Singhvi S. Lymphoplasmacyte-rich meningioma with invasion of bone: A case report and review of literature. Asian J Neurosurg. 2016;11(4):448.CrossRef Kurmi DJ, Sharma A, Mittal RS, Singhvi S. Lymphoplasmacyte-rich meningioma with invasion of bone: A case report and review of literature. Asian J Neurosurg. 2016;11(4):448.CrossRef
Metadaten
Titel
A case of Lymphoplasmacyte-rich meningioma mimicking pachymeningitis
verfasst von
Yue Zhang
Xiang Zhang
Abhijeet Kumar Bhekharee
Zunguo Du
Shuguang Chu
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
BMC Neurology / Ausgabe 1/2022
Elektronische ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-022-02794-z

Weitere Artikel der Ausgabe 1/2022

BMC Neurology 1/2022 Zur Ausgabe

Neu in den Fachgebieten Neurologie und Psychiatrie

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.